Clinical Trial Update: ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates Abcuro's ABC008 is being studied in Phase 1/2 for T-cell Large Granular Lymphocytic Leukemia, with the study currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Large Granular Lymphocytic Leukemia

Drugs mentioned

• ABC008

Snippet

Sponsor: Abcuro, Inc. | Conditions: T-cell Large Granular Lymphocytic Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING